{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:14:50Z","timestamp":1791519290502,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Project of Xuzhou Medical Science and Technology Innovation Project","award":["XWKYHT20230034"],"award-info":[{"award-number":["XWKYHT20230034"]}]},{"name":"Xuzhou Pengcheng Talents -Medical Key Talent Project","award":["XWRCHT20220056"],"award-info":[{"award-number":["XWRCHT20220056"]}]},{"name":"333 Talent Fund of the Organization Department of Jiangsu Provincial Party Committee","award":["(2022) 3-12-134"],"award-info":[{"award-number":["(2022) 3-12-134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04578-4","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:04:03Z","timestamp":1766732643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of autotaxin sensitizes colon cancer to radiation by suppressing LPAR2-AKT survival signaling"],"prefix":"10.1186","volume":"26","author":[{"given":"Yingnan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6885-145X","authenticated-orcid":false,"given":"Shengcheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9081-8438","authenticated-orcid":false,"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"3","key":"4578_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4578_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejso.2022.08.008","volume":"49","author":"B Zamaray","year":"2023","unstructured":"Zamaray B, van Velzen RA, Snaebjornsson P, Consten ECJ, Tanis PJ, van Westreenen HL. Dutch complex colon cancer I: outcomes of patients with perforated colon cancer: A systematic review. Eur J Surg Oncol. 2023;49(1):1\u20138.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4578_CR3","first-page":"198","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas JC, Ramnaraign B, George TJ. Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer. 2022;21(3):198\u2013203.","journal-title":"Clin Colorectal Cancer"},{"issue":"12","key":"4578_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.annonc.2021.08.1752","volume":"32","author":"T Yoshino","year":"2021","unstructured":"Yoshino T, Argiles G, Oki E, Martinelli E, Taniguchi H, Arnold D, Mishima S, Li Y, Smruti BK, Ahn JB, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol. 2021;32(12):1496\u2013510.","journal-title":"Ann Oncol"},{"key":"4578_CR5","doi-asserted-by":"publisher","first-page":"1590219","DOI":"10.3389\/fimmu.2025.1590219","volume":"16","author":"Z Jingjing","year":"2025","unstructured":"Jingjing Z, Kun W, Yanyu Q, Mengjie Z, Yunqing C, Yulong T, Xuelong J, Xiaojie T, Haitao J, Feng H. Radiation therapy induced intestinal barrier damage and repair process - differences in salivary metabolites and monitoring of intestinal barrier function. Front Immunol. 2025;16:1590219.","journal-title":"Front Immunol"},{"issue":"3","key":"4578_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ijrobp.2025.06.3850","volume":"123","author":"L Xiao","year":"2025","unstructured":"Xiao L, Sun J, Wang L, Liu M, Wang X, Wang Y, et al. To explore the efficacy and safety of neoadjuvant chemoradiation therapy in locally advanced colon cancer: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2025;123(3):817\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4578_CR7","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s13277-013-1465-9","volume":"35","author":"SH Sahlberg","year":"2014","unstructured":"Sahlberg SH, Gustafsson AS, Pendekanti PN, Glimelius B, Stenerlow B. The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines. Tumour Biol. 2014;35(4):3525\u201334.","journal-title":"Tumour Biol"},{"issue":"1","key":"4578_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-018-0316-0","volume":"17","author":"YH Yuan","year":"2019","unstructured":"Yuan YH, Wang HY, Lai Y, Zhong W, Liang WL, Yan FD, Yu Z, Chen JK, Lin Y. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC\/AKT\/MAPK signaling pathway. Cell Commun Signal. 2019;17(1):9.","journal-title":"Cell Commun Signal"},{"key":"4578_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092660","author":"M Russo","year":"2023","unstructured":"Russo M, Moccia S, Luongo D, Russo GL. Senolytic flavonoids enhance type-I and type-II cell death in human radioresistant colon cancer cells through AMPK\/MAPK pathway. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15092660.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4578_CR10","doi-asserted-by":"publisher","first-page":"e94621","DOI":"10.1371\/journal.pone.0094621","volume":"9","author":"SH Sahlberg","year":"2014","unstructured":"Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlow B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS ONE. 2014;9(4):e94621.","journal-title":"PLoS ONE"},{"key":"4578_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148135","author":"T Suwa","year":"2021","unstructured":"Suwa T, Kobayashi M, Shirai Y, Nam JM, Tabuchi Y, Takeda N, et al. SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.148135.","journal-title":"JCI Insight"},{"issue":"21","key":"4578_CR12","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/sj.onc.1206385","volume":"22","author":"A Unruh","year":"2003","unstructured":"Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, Katschinski DM, Wenger RH. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene. 2003;22(21):3213\u201320.","journal-title":"Oncogene"},{"issue":"42","key":"4578_CR13","doi-asserted-by":"publisher","first-page":"44758","DOI":"10.18632\/oncotarget.5815","volume":"6","author":"S Pathak","year":"2015","unstructured":"Pathak S, Meng WJ, Nandy SK, Ping J, Bisgin A, Helmfors L, Waldmann P, Sun XF. Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner. Oncotarget. 2015;6(42):44758\u201380.","journal-title":"Oncotarget"},{"issue":"12","key":"4578_CR14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.6004\/jnccn.2017.7011","volume":"15","author":"ME Charlton","year":"2017","unstructured":"Charlton ME, Kahl AR, Greenbaum AA, Karlitz JJ, Lin C, Lynch CF, et al. KRAS testing, tumor location, and survival in patients with stage IV colorectal cancer: SEER 2010\u20132013. J Natl Compr Canc Netw. 2017;15(12):1484\u201393.","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"4578_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.31083\/j.fbl2809197","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Qu W, Tu J, Qi H. Implications of advances in studies of O(6)-Methylguanine-DNA- methyltransferase for tumor prognosis and treatment. Front Biosci (Landmark Ed). 2023;28(9):197.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"4578_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1667\/RR2390.1","volume":"175","author":"W Goetz","year":"2011","unstructured":"Goetz W, Morgan MN, Baulch JE. The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat Res. 2011;175(5):575\u201387.","journal-title":"Radiat Res"},{"issue":"4","key":"4578_CR17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.bbrc.2006.02.085","volume":"342","author":"LM Orre","year":"2006","unstructured":"Orre LM, Stenerlow B, Dhar S, Larsson R, Lewensohn R, Lehtio J. P53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line. Biochem Biophys Res Commun. 2006;342(4):1211\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4578_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jop.13561","volume":"53","author":"R Yang","year":"2024","unstructured":"Yang R, Zhang S, Wang L, Chen Y, Chen X, Xia J, Ren X, Cheng B, Chen X. Radiation-induced exosomes promote oral squamous cell carcinoma progression via enhancing SLC1A5-glutamine metabolism. J Oral Pathol Med. 2024;53(7):458\u201367.","journal-title":"J Oral Pathol Med"},{"key":"4578_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216498","author":"D Molodtsova","year":"2023","unstructured":"Molodtsova D, Guryev DV, Osipov AN. Composition of conditioned media from radioresistant and chemoresistant cancer cells reveals miRNA and other secretory factors implicated in the development of resistance. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242216498.","journal-title":"Int J Mol Sci"},{"key":"4578_CR20","doi-asserted-by":"publisher","first-page":"103452","DOI":"10.1016\/j.redox.2024.103452","volume":"79","author":"B Alkotub","year":"2025","unstructured":"Alkotub B, Bauer L, Bashiri Dezfouli A, Hachani K, Ntziachristos V, Multhoff G, Kafshgari MH. Radiosensitizing capacity of Fenofibrate in glioblastoma cells depends on lipid metabolism. Redox Biol. 2025;79:103452.","journal-title":"Redox Biol"},{"issue":"2","key":"4578_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","volume":"46","author":"LA van Meeteren","year":"2007","unstructured":"van Meeteren LA, Moolenaar WH. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res. 2007;46(2):145\u201360.","journal-title":"Prog Lipid Res"},{"key":"4578_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/cells10040939","volume":"10(4)","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li M, Yin N, Zhang J. The expression regulation and biological function of autotaxin. Cells. 2021;10(4):939. https:\/\/doi.org\/10.3390\/cells10040939.","journal-title":"Cells"},{"key":"4578_CR23","doi-asserted-by":"publisher","first-page":"216226","DOI":"10.1016\/j.canlet.2023.216226","volume":"566","author":"Y Long","year":"2023","unstructured":"Long Y, Wang Y, Qu M, Zhang D, Zhang X, Zhang J. Combined inhibition of EZH2 and the autotaxin-LPA-LPAR2 axis exerts synergistic antitumor effects on colon cancer cells. Cancer Lett. 2023;566:216226.","journal-title":"Cancer Lett"},{"issue":"2","key":"4578_CR24","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1096\/fj.201801226R","volume":"33","author":"G Meng","year":"2019","unstructured":"Meng G, Tang X, Yang Z, Zhao Y, Curtis JM, McMullen TPW, Brindley DN. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer. FASEB J. 2019;33(2):1899\u2013910.","journal-title":"FASEB J"},{"issue":"19","key":"4578_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2217\/bmm-2023-0496","volume":"17","author":"A Baspinar","year":"2023","unstructured":"Baspinar A, Ozkan D, Tokgoz S, Ozkardes AB, Kaya IO. Diagnostic value of serum autotaxin level in colorectal cancer. Biomark Med. 2023;17(19):787\u201398.","journal-title":"Biomark Med"},{"issue":"5","key":"4578_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cmet.2019.09.016","volume":"30","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang Y, Wang P, Zhang SY, Dong Y, Zeng G, Yan Y, Sun L, Wu Q, Liu H, et al. Adipocyte Hypoxia-Inducible factor 2alpha suppresses atherosclerosis by promoting adipose ceramide catabolism. Cell Metab. 2019;30(5):937\u2013e951935.","journal-title":"Cell Metab"},{"issue":"W1","key":"4578_CR27","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, Spigelman AF, MacDonald PE, Wishart DS, Li S, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52(W1):W398\u2013406.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4578_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrm3188","volume":"12","author":"WH Moolenaar","year":"2011","unstructured":"Moolenaar WH, Perrakis A. Insights into autotaxin: how to produce and present a lipid mediator. Nat Rev Mol Cell Biol. 2011;12(10):674\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4578_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","volume":"6","author":"LHM Geraldo","year":"2021","unstructured":"Geraldo LHM, Spohr T, Amaral RFD, Fonseca A, Garcia C, Mendes FA, Freitas C, dosSantos MF, Lima FRS. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther. 2021;6(1):45.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4578_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-025-02423-4","volume":"10","author":"R Nadhan","year":"2025","unstructured":"Nadhan R, Nath K, Basu S, Isidoro C, Song YS, Dhanasekaran DN. Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks. Signal Transduct Target Ther. 2025;10(1):337.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"4578_CR31","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A Lanczky","year":"2021","unstructured":"Lanczky A, Gyorffy B. Web-Based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633.","journal-title":"J Med Internet Res"},{"issue":"3","key":"4578_CR32","first-page":"100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5(3):100625.","journal-title":"Innov (Camb)"},{"issue":"3","key":"4578_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jtho.2020.11.022","volume":"16","author":"MB Nilsson","year":"2021","unstructured":"Nilsson MB, Robichaux J, Herynk MH, Cascone T, Le X, Elamin Y, Patel S, Zhang F, Xu L, Hu L, et al. Altered regulation of HIF-1alpha in Naive- and Drug-Resistant EGFR-Mutant NSCLC: implications for a vascular endothelial growth Factor-Dependent phenotype. J Thorac Oncol. 2021;16(3):439\u201351.","journal-title":"J Thorac Oncol"},{"issue":"14","key":"4578_CR34","first-page":"3374","volume":"59","author":"DH Gorski","year":"1999","unstructured":"Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999;59(14):3374\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"4578_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1667\/0033-7587(2002)157[0045:TAASAS]2.0.CO;2","volume":"157","author":"S Ning","year":"2002","unstructured":"Ning S, Laird D, Cherrington JM, Knox SJ. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation. Radiat Res. 2002;157(1):45\u201351.","journal-title":"Radiat Res"},{"issue":"1","key":"4578_CR36","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1038\/s41598-022-09565-3","volume":"12","author":"T Hauck","year":"2022","unstructured":"Hauck T, Kadam S, Heinz K, Garcia Peraza M, Schmid R, Kremer AE, Wolf K, Bauer A, Horch RE, Arkudas A, et al. Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines. Sci Rep. 2022;12(1):5565.","journal-title":"Sci Rep"},{"issue":"8","key":"4578_CR37","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/2159-8290.CD-21-1181","volume":"12","author":"CS Chae","year":"2022","unstructured":"Chae CS, Sandoval TA, Hwang SM, Park ES, Giovanelli P, Awasthi D, Salvagno C, Emmanuelli A, Tan C, Chaudhary V, et al. Tumor-Derived lysophosphatidic acid blunts protective type I interferon responses in ovarian cancer. Cancer Discov. 2022;12(8):1904\u201321.","journal-title":"Cancer Discov"},{"issue":"2","key":"4578_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s43018-023-00703-y","volume":"5","author":"S Bhattacharyya","year":"2024","unstructured":"Bhattacharyya S, Oon C, Diaz L, Sandborg H, Stempinski ES, Saoi M, Morgan TK, Lopez CS, Cross JR, Sherman MH. Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. Nat Cancer. 2024;5(2):283\u201398.","journal-title":"Nat Cancer"},{"issue":"1","key":"4578_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04578-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:38:52Z","timestamp":1769600332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04578-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4578"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04578-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were evaluated and authorized by the Institutional Animal Care and Use Committee at Xuzhou Medical University (Approval No.202302T013), following the guidelines established by the U.S. Department of Agriculture, the International Association for the Assessment and Accreditation of Laboratory Animal Care, and the National Institutes of Health (Bethesda, MD).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}